Paul Govern Archive — Page 36 of 55

Close-up of rows of pink and white cylindrical rings with central holes, arranged in a repeating pattern.
April 19, 2018

New labeling system speeds clinical lab turnaround times

Much of everyday clinical decision-making is informed by lab tests performed rapidly on automated instrumentation — basic metabolic panels, complete blood counts, all the lab orders for which clinicians expect quick results.

White pills scattered on a surface beside an overturned amber prescription bottle with more pills spilling from its opening.
April 19, 2018

VUMC drug repurposing initiative gaining momentum

Drug repurposing involves establishing an additional approved indication for a drug already at market.

Hand holding a smartphone displaying a grid of app icons, with a blurred laptop in the background.
April 2, 2018

VUMC health records now available on iPhone Health app

Vanderbilt University Medical Center is among an initial 39 health systems supporting a new health records feature on the iPhone.

Several brightly colored traditional analog alarm clocks, including red, brown, yellow, and pink clocks, arranged against a white background.
March 29, 2018

Study finds broken circadian clock in human tumors

Human tumors appear to have a broken circadian clock, researchers at Vanderbilt University Medical Center report in the journal PeerJ.

Illustration of human intestinal tract
March 22, 2018

Grant bolsters study of potential new therapy for C. diff infection

According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.

Futuristic blue digital illustration combining a DNA double helix with circuit-board patterns, glowing numbers, and streams of binary code.
March 1, 2018

Study reveals safety signal from genes that mimic drugs

Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.